How to cite item

Off pump hybrid extra-anatomic techniques for aortic arch repair—own experience

  
@article{JTD29472,
	author = {Piotr Buczkowski and Mateusz Puslecki and Sebastian Stefaniak and Robert Juszkat and Jerzy Kulesza and Marcin Misterski and Tomasz Urbanowicz and Marcin Ligowski and Bartosz Zabicki and Marek Dabrowski and Lukasz Szarpak and Damian Gorczyca and Marek Jemielity and Bartłomiej Perek},
	title = {Off pump hybrid extra-anatomic techniques for aortic arch repair—own experience},
	journal = {Journal of Thoracic Disease},
	volume = {11},
	number = {6},
	year = {2019},
	keywords = {},
	abstract = {Background: Treatment of the aortic arch pathologies is technically challenging. In this study we assess early and late outcomes of hybrid aortic arch repairs that comprise extra-anatomic surgical procedures completed by thoracic endovascular interventions [thoracic endovascular aortic repair (TEVAR)]. 
Methods: Since 2007, 21 patients (8 women and 13 men) with a median age of 48 years have undergone hybrid procedures for aortic arch pathologies. All of them were treated without cardio-pulmonary bypass. All survivors were followed up regularly and imaging examination were performed. A technical success, procedural complications as well as the early and late mortality and morbidity rates were evaluated. 
Results: All patients survived surgery and TEVAR was technically successful in all of them. However, 2 individuals died (in-hospital mortality rate 9.5%) during in-hospital stay, both due to multi-organ failure (MOF). Additionally, one patient developed symptoms of cerebral stroke, another one of spinal cord ischemia. During the follow-up that ranged from 6 to 118 months and was completed by 100% of the survivors, one patient died 3 years after procedure because of sepsis (aorto-oesophageal fistula prior to intervention) and late vascular graft occlusions were noted in three cases.
Conclusions: Hybrid procedures on the aortic arch that comprise surgical and endovascular interventions has become an attractive and safe therapeutic option with acceptable mortality and morbidity rate. They may be considered as a method of choice in treatment of the elderly and high-risk patients.},
	issn = {2077-6624},	url = {https://jtd.amegroups.org/article/view/29472}
}